Public-registry site landscape for NCT05480761, a Congenital Sucrase-Isomaltase Deficiency study sponsored by QOL Medical, LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05480761 (registry record) |
| Sponsor | QOL Medical, LLC |
| Condition(s) | Congenital Sucrase-Isomaltase Deficiency; CSID; Sucrase Isomaltase Deficiency |
| Phase | PHASE4 |
| Listed sites | 20 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05480761 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →